Pediatric Noninfectious Uveitis in the US
Dr. Akshay Thomas Contributes to Landmark Pediatric Uveitis Study
At Tennessee Retina, our physicians are committed to advancing knowledge and improving care for complex eye conditions. We’re proud to highlight Dr. Akshay Thomas, our uveitis specialist, for his contribution to a recent study on pediatric noninfectious uveitis, published in Ophthalmology Retina.
The study analyzed 5,722 children with uveitis in the U.S., drawing from the IRIS® Registry, one of the largest ophthalmology databases in the country.
Key findings included:
Prevalence & demographics: Pediatric noninfectious uveitis affected 11.9 per 100,000 children, representing 2.1% of all uveitis cases. Patients were evenly split between sexes, mostly White, with an average age of 12.5 years at diagnosis.
Types of uveitis: Most children had anterior uveitis (68.7%), with fewer cases of intermediate, posterior, or panuveitis.
Treatment patterns: Local corticosteroids were used in 91% of cases, and methotrexate was the most common steroid-sparing therapy.
Outcomes: Vision significantly improved after one year, though 9.3% of eyes experienced severe vision loss. Complications like cataracts and macular edema occurred in roughly 21% of eyes, while only 5% required ocular surgery.
This research emphasizes the importance of early detection and personalized treatment for pediatric patients with uveitis. Dr. Thomas’s contribution highlights Tennessee Retina’s commitment to both clinical excellence and innovative research in eye care.
📚 Read the full study: HERE
